Clinical Efficacy and Safety of Jingfang Granules in Treating Diarrhea-Predominant Irritable Bowel Syndrome With Cold-Dampness Disturbing Spleen Syndrome

NCT07688161 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Diarrhea-predominant Irritable Bowel Syndrome

Interventions

DRUG: Trimebutine Maleate Tablets
DRUG: Jingfang Granules

Sponsor

Nanjing First Hospital, Nanjing Medical University